Financial Sands Shift as Sparks Fly in VP Debate
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.32 +1.84%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 7.1%
EPS Growth %: -12.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 7.1%
EPS Growth %: -12.8%
Join SI Premium – FREE
With sparks from the Thursday's VP debate still glowing in the minds of voters, investors are reassessing the presidential election race and what it means for the equities they own.
Unlike the Romney vs. Obama debate, last night's face-off between Vice President Joe Biden and hopeful Paul Ryan left no doubt in viewers minds that the two parties remain diametrically opposed, with key differences that will effect various sectors of the economy. The most likely areas to be affected include the fiscal cliff, the financial and healthcare sector, oil and alternative energy, and defense.
To sum it up, investors following the election think an Obama/Biden victor will favor alternative energy, generic-drug makers, and hospital.
A Romney/Ryan win, on the other hand, would favor insurers, oil companies, big banks, and defense contractors.
Speculation is also growing that Biden's wry smile could mean it's time to take profit in Pfizer (NYSE: PFE), the maker of Viagra.
Unlike the Romney vs. Obama debate, last night's face-off between Vice President Joe Biden and hopeful Paul Ryan left no doubt in viewers minds that the two parties remain diametrically opposed, with key differences that will effect various sectors of the economy. The most likely areas to be affected include the fiscal cliff, the financial and healthcare sector, oil and alternative energy, and defense.
To sum it up, investors following the election think an Obama/Biden victor will favor alternative energy, generic-drug makers, and hospital.
A Romney/Ryan win, on the other hand, would favor insurers, oil companies, big banks, and defense contractors.
Speculation is also growing that Biden's wry smile could mean it's time to take profit in Pfizer (NYSE: PFE), the maker of Viagra.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer (PFE) Declares $0.43 Quarterly Dividend; 7.1% Yield
- Pfizer Declares Third-Quarter 2026 Dividend
- FDA approves Pfizer's Ibrance for HR+, HER2+ metastatic breast cancer
Create E-mail Alert Related Categories
Insiders' BlogRelated Entities
Barack ObamaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
